Radionuclide targeted therapy, theranostics, and precision medicine in the era of hybrid imaging: an important pillar in cancer care
Cancer is one of the leading causes of death worldwide due to non-communicable diseases. In 2020, the World Health Organization reported that there were approximately 48,000 new cancer cases per year in Malaysia, the majority of which were breast cancers, followed by colorectal and lung cancers...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Universiti Putra Malaysia
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/102986/ https://medic.upm.edu.my/upload/dokumen/20220715162631Editorial_July_2022.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Putra Malaysia |
| Summary: | Cancer is one of the leading causes of death worldwide
due to non-communicable diseases. In 2020, the
World Health Organization reported that there were
approximately 48,000 new cancer cases per year in
Malaysia, the majority of which were breast cancers,
followed by colorectal and lung cancers (1). Among
Malaysian men, the top three cancers were lung,
colorectal and prostate cancers, whereas Malaysian
women succumbed mostly to breast cancer, followed
by colorectal and ovarian cancers (1). The alarming
rise in cancer cases makes oncology services ever more
pertinent, involving a spectrum of work that translates
from bench side to bedside. Hence making synergistic
works by the scientists and clinicians available for
cancer care. |
|---|